Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158613 · ClinicalTrials.gov registry record · Phase 4
Study of the Treatment of Articular Repair (STAR)
A Phase 4 study, sponsored by Vericel Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 126
- Enrollment target
NCT00158613 is a Phase 4 study that has completed, run by Vericel Corporation. The registered enrollment target is 126 participants.
The verdict
NCT00158613, a Phase 4 study, has completed, sponsored by Vericel Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 126 participants
- Enrollment target
Study Summary
This study is a prospective, longitudinal, multi-center, within patient evaluation of patients with articular cartilage defects of the knee who have had an inadequate response to a prior non-Carticel surgical treatment. Patients who met eligibility criteria were enrolled in the study. Subsequent to implantation with Carticel patients have follow-up every 6-months up to 48-months.
Interventions
- BIOLOGICAL Carticel (autologous cultured chondrocyte) implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2000-03 |
| Est. Completion | 2005-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158613
The ClinicalTrials.gov registry entry for NCT00158613 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vericel Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carticel (autologous cultured chondrocyte) implantation is the first listed.
NCT00158613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158613 about?
NCT00158613 is a clinical study titled "Study of the Treatment of Articular Repair (STAR)". This study is a prospective, longitudinal, multi-center, within patient evaluation of patients with articular cartilage defects of the knee who have had an inadequate response to a prior non-Carticel surgical treatment. Patients who met eligibility criteria were enrolled in the study. Subsequent to ...
What is the current status of trial NCT00158613?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 126 participants. The study started on 2000-03. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00158613?
The interventions under investigation include: Carticel (autologous cultured chondrocyte) implantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT00158613?
This trial is sponsored by Vericel Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.